“The Department of Health and Human Services has named a new adviser to oversee its drug pricing initiatives.”
“John O’Brien, a pharmacist and adviser to HHS Secretary Alex Azar on health reform and drug pricing policy, was named senior adviser for drug pricing reform, HHS announced. He joined HHS after serving as…” Read the full article here.
Source: HHS taps former CareFirst Blue Cross Blue Shield executive as senior drug pricing adviser – By Paige Minemyer, December 6, 2018. FierceHealthcare.
